SCHEMBL563259

SCHEMBL563259

NC1=NS(=O)(=O)Nc2nc(CCc3ccccc3)[nH]c21

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 3/20 0.42
MAPT P10636 3/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
ALDH1A1 P00352 1/20 0.42
NPC1 O15118 1/20 0.41
MAPK13 O15264 1/20 0.40
GCGR P47871 1/20 0.40
MAPK12 P53778 1/20 0.40
MAPK11 Q15759 1/20 0.40
MAPK14 Q16539 1/20 0.40
RNASEH1 O60930 1/20 0.39
DAO P14920 2/20 0.38
BACE1 P56817 1/20 0.38
TUBB4A P04350 1/20 0.37
TUBB P07437 1/20 0.37
TUBA3C P0DPH7 1/20 0.37
TUBA1B P68363 1/20 0.37
TUBA4A P68366 1/20 0.37
TUBB4B P68371 1/20 0.37
TUBB3 Q13509 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL563044 0.76 ADORA3 (0.31)
SCHEMBL562413 0.75 MAPK13 (0.43) RAB9AMAPTSMN1; SMN2ALDH1A1NPC1
SCHEMBL15434389 0.68 DHFR (0.39) BACE1HTT
SCHEMBL561997 0.64 CDK5 (0.36) BACE1
SCHEMBL25975569 0.61 MAOB (0.47) RAB9AMAPTSMN1; SMN2ALDH1A1NPC1
SCHEMBL9790418 0.59 ALPL (0.51) RAB9AMAPTSMN1; SMN2ALDH1A1NPC1
SCHEMBL10704195 0.59 RAB9A (0.46) RAB9AMAPTSMN1; SMN2ALDH1A1NPC1
SCHEMBL28537178 0.59 RAB9A (0.54) RAB9AMAPTSMN1; SMN2ALDH1A1NPC1
SCHEMBL784574 0.59 RAB9A (1.00) RAB9AMAPTSMN1; SMN2ALDH1A1NPC1
SCHEMBL30583066 0.59 RAB9A (1.00) RAB9AMAPTSMN1; SMN2ALDH1A1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8815846-B2 Family of antichagasics derived from imidazo[4,5-C][1,2,6]thiadiazine 2,2-dioxide UNIVERSIDAD DE LA REPUBLICA DE URUGUAY (UY) 2014-08-26 US claimed
US-20120035160-A1 NEW FAMILY OF ANTICHAGASICS DERIVED FROM IMIDAZO[4,5-C][1,2,6]THIADIAZINE 2,2-DIOXIDE UNIVERSIDAD DE LA REPUB'LICA URUGUAY (UY) 2012-02-09 US claimed
EP-2392577-A1 NEW FAMILY OF ANTICHAGASICS DERIVED FROM IMIDAZO[4,5-C][1,2,6]THIADIAZINE 2,2-DIOXIDE Consejo Superior de Investigaciones Científicas (CSIC) (ES) 2011-12-07 EP claimed
US-8815846-B2 Family of antichagasics derived from imidazo[4,5-C][1,2,6]thiadiazine 2,2-dioxide UNIVERSIDAD DE LA REPUBLICA DE URUGUAY (UY) 2014-08-26 US disclosed
US-8815846-B2 Family of antichagasics derived from imidazo[4,5-C][1,2,6]thiadiazine 2,2-dioxide UNIVERSIDAD DE LA REPUBLICA DE URUGUAY (UY) 2014-08-26 US disclosed
US-20120035160-A1 NEW FAMILY OF ANTICHAGASICS DERIVED FROM IMIDAZO[4,5-C][1,2,6]THIADIAZINE 2,2-DIOXIDE UNIVERSIDAD DE LA REPUB'LICA URUGUAY (UY) 2012-02-09 US disclosed
US-20120035160-A1 NEW FAMILY OF ANTICHAGASICS DERIVED FROM IMIDAZO[4,5-C][1,2,6]THIADIAZINE 2,2-DIOXIDE UNIVERSIDAD DE LA REPUB'LICA URUGUAY (UY) 2012-02-09 US disclosed
EP-2392577-A1 NEW FAMILY OF ANTICHAGASICS DERIVED FROM IMIDAZO[4,5-C][1,2,6]THIADIAZINE 2,2-DIOXIDE Consejo Superior de Investigaciones Científicas (CSIC) (ES) 2011-12-07 EP disclosed
EP-2392577-A1 NEW FAMILY OF ANTICHAGASICS DERIVED FROM IMIDAZO[4,5-C][1,2,6]THIADIAZINE 2,2-DIOXIDE Consejo Superior de Investigaciones Científicas (CSIC) (ES) 2011-12-07 EP disclosed
WO-2010086481-A1 NEW FAMILY OF ANTICHAGASICS DERIVED FROM IMIDAZO[4,5-C][1,2,6]THIADIAZINE 2,2-DIOXIDE CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS (CSIC) (ES) 2010-08-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120035160-A1 NEW FAMILY OF ANTICHAGASICS DERIVED FROM IMIDAZO[4,5-C][1,2,6]THIADIAZINE 2,2-DIOXIDE THOC2, TUBGCP2, TBC1D5 RAB9A 2909/4885MAPT 4013/4885SMN1; SMN2 2009/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.